{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:39:18Z","timestamp":1791031158632,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81000544"],"award-info":[{"award-number":["81000544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171209"],"award-info":[{"award-number":["81171209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Natural Science Foundation, China","award":["ZR2010HQ004"],"award-info":[{"award-number":["ZR2010HQ004"]}]},{"name":"Shandong Provincial Natural Science Foundation, China","award":["ZR2011HZ001"],"award-info":[{"award-number":["ZR2011HZ001"]}]},{"name":"Medicine and Health Science Technology Development Project of Shandong Province","award":["2011WSA02018"],"award-info":[{"award-number":["2011WSA02018"]}]},{"name":"Medicine and Health Science Technology Development Project of Shandong Province","award":["2011WSA02020"],"award-info":[{"award-number":["2011WSA02020"]}]},{"name":"Shandong Provincial Outstanding Medical Academic Professional Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.neurobiolaging.2013.01.010","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T08:05:23Z","timestamp":1360656323000},"page":"1921.e17-1921.e23","source":"Crossref","is-referenced-by-count":24,"title":["Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese"],"prefix":"10.1016","volume":"34","author":[{"given":"Jin-Tai","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1212\/WNL.0b013e3182553c48","article-title":"Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory","volume":"78","author":"Barral","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J.\u00a0Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","article-title":"The genetics of Alzheimer's disease","volume":"107","author":"Bertram","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-7-3","article-title":"Both common variations and rare non-synonymous substitutions and small insertion\/deletions in CLU are associated with increased Alzheimer risk","volume":"16","author":"Bettens","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.neurobiolaging.2009.03.013","article-title":"Meta-analysis of linkage studies for Alzheimer's disease\u2013a web resource","volume":"30","author":"Butler","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archneurol.2010.147","article-title":"Replication of CLU, CR1, and PICALM associations with alzheimer disease","volume":"67","author":"Carrasquillo","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1326-7-41","article-title":"Mass spectrometry quantification of clusterin in the human brain","volume":"20","author":"Chen","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib9","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/hmg\/ddq221","article-title":"Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals","volume":"19","author":"Corneveaux","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib10","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1073\/pnas.162228299","article-title":"Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease","volume":"99","author":"DeMattos","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib11","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/bi00474a025","article-title":"Apolipoprotein J: structure and tissue distribution","volume":"29","author":"de Silva","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib12","doi-asserted-by":"crossref","first-page":"1846.e7","DOI":"10.1016\/j.neurobiolaging.2012.01.110","article-title":"Implication of common and disease specific variants in CLU, CR1, and PICALM","volume":"33","author":"Ferrari","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000331276","article-title":"Association of clusterin gene polymorphisms with late-onset Alzheimer's disease","volume":"32","author":"Gu","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib15","doi-asserted-by":"crossref","first-page":"e9510","DOI":"10.1371\/journal.pone.0009510","article-title":"Genetic variability in CLU and its association with Alzheimer's disease","volume":"5","author":"Guerreiro","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","article-title":"Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes","volume":"67","author":"Jun","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neurobiolaging.2010.04.015","article-title":"Association of CLU and PICALM variants with Alzheimer's disease","volume":"33","author":"Kamboh","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1479-8301.2010.00346.x","article-title":"Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population","volume":"11","author":"Komatsu","year":"2011","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated withAlzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archneurol.2010.292","article-title":"Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals","volume":"68","author":"Lee","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/exnr.1998.6892","article-title":"Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease","volume":"154","author":"Lidstr\u00f6m","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10654-012-9650-5","article-title":"Genetic polymorphisms of clusterin gene are associated with a decreased risk of Alzheimer's disease","volume":"27","author":"Lin","year":"2012","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/HYPERTENSIONAHA.107.098897","article-title":"Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase","volume":"51","author":"Makhanova","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4137\/CIN.S10176","article-title":"Haploinsufficiency of tumor suppressor genes is driven by the cumulative effect of microRNAs, microRNA binding site polymorphisms and microRNA polymorphisms: an in silico approach","volume":"11","author":"Manikandan","year":"2012","journal-title":"Cancer Inform."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/bj3160671","article-title":"Apolipoprotein J and Alzheimer's amyloid beta solubility","volume":"316","author":"Matsubara","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer'sdisease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuint.2005.12.005","article-title":"Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms","volume":"48","author":"Nilselid","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1006\/bbrc.1994.2580","article-title":"Purification and characterization of brain clusterin","volume":"204","author":"Oda","year":"1994","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archgenpsychiatry.2010.196","article-title":"The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels","volume":"68","author":"Schjeide","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2010-101359","article-title":"Linkage to the 8p21.1 region Including the CLU gene in age at onset stratified Alzheimer's disease families","volume":"23","author":"Sill\u00e9n","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12035-012-8359-5","article-title":"Non-coding RNAs in Alzheimer's disease","volume":"47","author":"Tan","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s004390050234","article-title":"Polymorphisms in the human apolipoprotein-J\/clusterin gene: ethnic variation and distribution in Alzheimer's disease","volume":"98","author":"Tycko","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-394317-0.00011-X","article-title":"Clusterin in Alzheimer's disease","volume":"56","author":"Wu","year":"2012","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-2011-111844","article-title":"Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease","volume":"29","author":"Xing","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib39","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1096\/fj.06-7986com","article-title":"The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures","volume":"21","author":"Yerbury","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib40","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.cca.2010.06.013","article-title":"Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease","volume":"411","author":"Yu","year":"2010","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","article-title":"The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy","volume":"45","author":"Yu","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2013.01.010_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1750-3639.2005.tb00103.x","article-title":"Neurovascular pathways and Alzheimer amyloid beta-peptide","volume":"15","author":"Zlokovic","year":"2005","journal-title":"Brain Pathol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T16:42:33Z","timestamp":1562690553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0197458013000407"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.01.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}